About DrugCard
DrugCard is a company based in Tallinn (Estonia) founded in 2020. DrugCard has raised $288.35 thousand across 3 funding rounds from investors including Google, Farmak and New Nordic Ventures. DrugCard operates in a competitive market with competitors including Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others.
- Headquarter Tallinn, Estonia
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Drugcards Oü
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$288.35 K (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Google
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of DrugCard
Unlock access to complete
Funding Insights of DrugCard
DrugCard has successfully raised a total of $288.35K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(09 Dec 2021)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Seed - DrugCard | Valuation | New Nordic Ventures |
|
| Mar, 2022 | Amount | Grant - DrugCard | Valuation |
investors |
|
| Dec, 2021 | Amount | Seed - DrugCard | Valuation | Think Bigger Capital , Farmak |
|
Investors in DrugCard
DrugCard has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Google, Farmak and New Nordic Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage investments are made in Eastern European enterprise software startups.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more
|
Founded Year | Domain | Location |
Investments & Acquisitions by DrugCard
Financial Statements - DrugCard
Drugcard Comparisons
Competitors of DrugCard
DrugCard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based pharmacovigilance platform is developed for report analysis and monitoring.
|
|
| domain | founded_year | HQ Location |
AI-based solutions for drug pharmacovigilance are provided.
|
|
| domain | founded_year | HQ Location |
Specialized pharmacovigilance software and services are developed and provided.
|
|
| domain | founded_year | HQ Location |
Adverse events and product quality are captured for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
|
Frequently Asked Questions about DrugCard
DrugCard was founded in 2020 and raised its 1st funding round 1 year after it was founded.
DrugCard is headquartered in Tallinn, Estonia.
Dmytro Horilyk is the current CEO of DrugCard.
DrugCard is a funded company, having raised a total of $288.35K across 3 funding rounds to date. The company's 1st funding round was a Seed of $288.35K, raised on Dec 09, 2021.
DrugCard was founded in 2020 in Tallinn, Estonia, within the pharmaceutical sector. Software solutions are offered to support pharmacovigilance processes, including legal compliance management, data analysis, and AI-enabled decision-making tools. Pharmacovigilance services are also extended to organizations to aid in regulatory adherence and risk assessment across global operations.
DrugCard's top competitors include biologit, Sentrx and My Meds & Me.
DrugCard has 4 investors. Key investors include Google, Farmak, New Nordic Ventures, and Think Bigger Capital.